Access cutting-edge glioblastoma treatment through this clinical trial at a research site in Austin. Study-provided care at no cost to qualified participants.
Access glioblastoma specialists in Austin at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glioblastoma treatment provided free
This is an open-label single arm study. All patients will receive the study drug. The aim of the study is to compare overall survival (OS) of patients with recurrent brain tumor, known as Glioblastoma (GBM) having high levels of a protein, Trophoblast cell surface antigen 2 (Trop-2), expression on treatment with Sacituzumab Govitecan (SG) versus lomustine only which has been used in the past.
Sponsor: The University of Texas Health Science Center at San Antonio
Check if you qualify for this glioblastoma clinical trial in Austin, TX
If you're searching for glioblastoma treatment options in Austin, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Austin research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glioblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.